Your browser doesn't support javascript.
loading
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan.
Chien, Li-Hsin; Chen, Tzu-Yu; Chen, Chung-Hsing; Chen, Kuan-Yu; Hsiao, Chin-Fu; Chang, Gee-Chen; Tsai, Ying-Huang; Su, Wu-Chou; Huang, Ming-Shyan; Chen, Yuh-Min; Chen, Chih-Yi; Liang, Sheng-Kai; Chen, Chung-Yu; Wang, Chih-Liang; Hung, Hsiao-Han; Jiang, Hsin-Fang; Hu, Jia-Wei; Rothman, Nathaniel; Lan, Qing; Liu, Tsang-Wu; Chen, Chien-Jen; Yang, Pan-Chyr; Chang, I-Shou; Hsiung, Chao A.
Afiliación
  • Chien LH; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
  • Chen TY; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
  • Chen CH; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
  • Chen KY; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan​.
  • Hsiao CF; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
  • Chang GC; Taiwan Lung Cancer Tissue/Specimen Information Resource Center, National Health Research Institutes, Zhunan, Taiwan.
  • Tsai YH; School of Medicine and Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Su WC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Huang MS; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
  • Chen YM; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Chen CY; Department of Respiratory Therapy, Chang Gung University, Taoyuan, Taiwan.
  • Liang SK; Department of Pulmonary and Critical Care, Xiamen Chang Gung Hospital, Xiamen, China.
  • Chen CY; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Wang CL; Department of Internal Medicine, E-Da Cancer Hospital, School of Medicine, I-Shou University, Kaohsiung, Taiwan.
  • Hung HH; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Jiang HF; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Hu JW; Institute of Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Rothman N; Division of Thoracic Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Lan Q; Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch, Hsinchu, Taiwan.
  • Liu TW; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Chen CJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan.
  • Yang PC; Department of Pulmonary and Critical Care, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Chang IS; National Institute of Cancer Research, National Health Research Institutes, Zhunan, Taiwan.
  • Hsiung CA; Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Taiwan.
Cancer Epidemiol Biomarkers Prev ; 31(12): 2208-2218, 2022 12 05.
Article en En | MEDLINE | ID: mdl-36129788
ABSTRACT

BACKGROUND:

Methods synthesizing multiple data sources without prospective datasets have been proposed for absolute risk model development. This study proposed methods for adapting risk models for another population without prospective cohorts, which would help alleviate the health disparities caused by advances in absolute risk models. To exemplify, we adapted the lung cancer risk model PLCOM2012, well studied in the west, for Taiwan.

METHODS:

Using Taiwanese multiple data sources, we formed an age-matched case-control study of ever-smokers (AMCCSE), estimated the number of ever-smoking lung cancer patients in 2011-2016 (NESLP2011), and synthesized a dataset resembling the population of cancer-free ever-smokers in 2010 regarding the PLCOM2012 risk factors (SPES2010). The AMCCSE was used to estimate the overall calibration slope, and the requirement that NESLP2011 equals the estimated total risk of individuals in SPES2010 was used to handle the calibration-in-the-large problem.

RESULTS:

The adapted model PLCOT-1 (PLCOT-2) had an AUC of 0.78 (0.75). They had high performance in calibration and clinical usefulness on subgroups of SPES2010 defined by age and smoking experience. Selecting the same number of individuals for low-dose computed tomography screening using PLCOT-1 (PLCOT-2) would have identified approximately 6% (8%) more lung cancers than the US Preventive Services Task Forces 2021 criteria. Smokers having 40+ pack-years had an average PLCOT-1 (PLCOT-2) risk of 3.8% (2.6%).

CONCLUSIONS:

The adapted PLCOT models had high predictive performance. IMPACT The PLCOT models could be used to design lung cancer screening programs in Taiwan. The methods could be applicable to other cancer models.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Asunto de la revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Taiwán
...